Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Sara Gaafar Ibnauf Suliman: The Changing Role of Bariatric Surgery in the GLP-1 Era
Oct 1, 2026, 23:26

Sara Gaafar Ibnauf Suliman: The Changing Role of Bariatric Surgery in the GLP-1 Era

Sara Gaafar Ibnauf Suliman, President of Obesity Medicine Section at IFSO International Federation for the Surgery and other therapies for Obesity (IFSO), shared a post on LinkedIn:

“GLP1 receptor agonist usage has expanded exponentially, making some question the role of metabolic bariatric surgery (MBS) in the management of obesity.

In this article published today in the The Lancet Obstetrics, Gynaecology, and Women’s Health we present a balanced view on why both MBS and GLP1RAs have an important role to play in the management of obesity and particularly in women.”

Title: Obesity medications in women’s health: is metabolic bariatric surgery still relevant?

Authors: Sara G I Suliman, Ali Aminian, Mohammed Al-Hadad, Alexander Dimitri Miras, Dimitris Papamargaritis, Melanie J Davies, Susan E Ozanne, Claire L Meek, Tricia M-M Tan

Sara Gaafar Ibnauf Suliman

Stay updated with Hemostasis Today.